Impact of the COVID-19 pandemic on liver donation and transplantation: A review of the literature

Table 3 Mortality, hospitalization, intensive care unit admission, and risk factors among liver transplantation recipients

Ref.	Registry	n	Mortality (%)	Hospital admission (%)	ICU admission (%)1	Major correlations with mortality
Polak et al[2], 2020	ELTR	272	15	N/A	14	sexage
Rabiee et al[45], 2020	COLD	112	22.3	72.3	26.8	N/A
Colmenero et al[44], 2020	SETH	111	18	86.5	10.8	Charlson comorbidity index; Male sex; Dyspnea at diagnosis; Immunosuppression with mycophenolate
Bhoori et al[49], 2020	–	111 (long term); 40 (short term)	30	N/A	N/A	N/A
Belli et al[48], 2020	ELTR/ELITA	103	16	66	15	N/A
Becchetti et al[43], 2020	–	57	12	72	7	N/A
Webb et al[42], 2020	COVID-hep and SECURE-cirrhosis	39	23	N/A	N/A	N/A
Patrono et al[41], 2020	–	10	10	N/A	N/A	N/A

¹Calculated as proportion of the total cohort. N/A: Not applicable; COLD: Consortium of investigators to study COVID-19 in chronic liver disease; ELITA: European Liver and Intestine Transplantation Association; ELTR: European Liver Transplant Registry; SETH: Spanish Society of Liver Transplantation; COVID: Coronavirus disease.